Ampicillin Resistance and Amoxicillin Efficacy
Yes, if a bacterial isolate is resistant to ampicillin, amoxicillin will also be ineffective in the vast majority of cases, because both drugs share the same core β-lactam structure and resistance mechanisms.
Shared Resistance Mechanisms
Resistance to ampicillin predicts resistance to amoxicillin because both are aminopenicillins that are inactivated by the same β-lactamase enzymes. 1 The FDA label for amoxicillin explicitly states that "resistance to amoxicillin is mediated primarily through enzymes called beta-lactamases that cleave the beta-lactam ring of amoxicillin, rendering it inactive." 1 These same β-lactamases cleave ampicillin's β-lactam ring through an identical mechanism.
Clinical Evidence of Cross-Resistance
Gram-Negative Organisms
For H. influenzae, 25-50% of non-typeable strains produce β-lactamase, rendering both ampicillin and amoxicillin ineffective. 2 The Taiwan pneumonia guidelines explicitly state that "amoxicillin and ampicillin should be used only when susceptibility is known" for H. influenzae infections. 2
For M. catarrhalis, up to 97.8% of clinical isolates produce β-lactamase and demonstrate ampicillin resistance. 2 These isolates are nonsusceptible to amoxicillin unless combined with a β-lactamase inhibitor (clavulanate). 3
For E. coli and other Enterobacteriaceae, cross-resistance between ampicillin and amoxicillin is nearly complete (>93%). 4 A 1993 study of 2,440 consecutive Enterobacteriaceae isolates documented that "cross-susceptibility and cross-resistance between ampicillin and amoxicillin was nearly complete." 4
Gram-Positive Organisms
For Enterococcus faecalis, ampicillin susceptibility accurately predicts amoxicillin susceptibility. 5 A 2012 study demonstrated that "ampicillin susceptibility can predict in vitro susceptibility of penicillin-resistant, ampicillin-susceptible E. faecalis isolates to amoxicillin." 5
For S. pneumoniae, both drugs share identical resistance patterns mediated by altered penicillin-binding proteins rather than β-lactamases. 6 The 2000 IDSA guidelines note that amoxicillin is actually more potent than penicillin against pneumococci, with higher MIC thresholds, but resistance mechanisms affect both aminopenicillins similarly. 6
Important Exceptions and Nuances
When Amoxicillin May Retain Activity Despite Ampicillin Resistance
Amoxicillin achieves higher serum and tissue concentrations than ampicillin, which may overcome low-level resistance in specific clinical scenarios. 6 For S. pneumoniae with intermediate penicillin resistance, high-dose amoxicillin (80-90 mg/kg/day) can achieve sinus fluid concentrations adequate to overcome resistance attributable to altered penicillin-binding proteins. 3
For vancomycin-resistant enterococci (VRE) causing urinary tract infections, high-dose ampicillin (18-30 g IV daily) or amoxicillin (500 mg every 8 hours) may achieve sufficient urinary concentrations to overcome ampicillin resistance. 7 A retrospective study showed 88.1% clinical eradication and 86% microbiological eradication for UTIs due to ampicillin-resistant VRE treated with ampicillin. 7
β-Lactamase Inhibitor Combinations
When β-lactamase production is the sole resistance mechanism, adding clavulanate to amoxicillin restores activity even when ampicillin alone is resistant. 3 Pediatric sinusitis guidelines recommend amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component) for β-lactamase-producing H. influenzae and M. catarrhalis. 3
Common Pitfalls to Avoid
Do not assume amoxicillin will work simply because it achieves higher tissue levels than ampicillin. While pharmacokinetic differences exist, they rarely overcome true enzymatic resistance. 4
Do not rely on ampicillin-sulbactam susceptibility to predict amoxicillin-clavulanate susceptibility. A 1999 study found marked discrepancies, with 26-52% resistance to ampicillin-sulbactam versus only 9-17% resistance to amoxicillin-clavulanate among E. coli isolates. 8
For organisms inherently resistant to ampicillin (e.g., B. pseudomallei), amoxicillin monotherapy is equally ineffective. 2 B. pseudomallei is inherently resistant to penicillin, ampicillin, and first/second-generation cephalosporins. 2
Practical Clinical Algorithm
If ampicillin resistance is documented by culture, assume amoxicillin resistance and select an alternative agent (e.g., cephalosporin, fluoroquinolone, or carbapenem depending on organism and infection site). 2
For β-lactamase-producing organisms (H. influenzae, M. catarrhalis, E. coli), use amoxicillin-clavulanate rather than amoxicillin alone. 3
For S. pneumoniae with intermediate penicillin resistance causing respiratory infections, high-dose amoxicillin (80-90 mg/kg/day) may overcome resistance despite ampicillin MIC elevation. 3
For VRE urinary tract infections only, consider high-dose ampicillin or amoxicillin despite in vitro resistance, given achievable urinary concentrations. 7